the Image

Clinical Trial Details

If you are a patient or a caregiver and would like to learn more our cancer clinical trials call toll-free 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials) or email cancerclinicaltrials@bsd.uchicago.edu .

Share this:
Brief Title A Study of Rovalpituzumab Tesirine to Study Cardiac Ventricular Repolarization in Subjects With Small Cell Lung Cancer
Official Title An Intensive QT/QTc Study to Investigate the Effects of Rovalpituzumab Tesirine on Cardiac Ventricular Repolarization in Subjects With Small Cell Lung Cancer
Principal Investigator Patel, Jyoti
Brief Summary Study to evaluate the effect of rovalpituzumab tesirine on cardiac ventricular repolarization in subjects with small cell lung cancer (SCLC).
Gender All
Ages 18 Years
Enrollment 50
Accepts Healthy Volunteers No
Lead Sponsor StemcentrxIndustry
Collaborator
Study Design
Study Phase Phase 1
Study Type Interventional
Contact Name Jonathan Goldman, MD
Contact Phone 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials)
Condition Small Cell Lung Carcinoma
Detail for Health Professional (on clinicaltrials.gov)
More clinical trials by this PI